Immunic (IMUX) Stock Price, News, Quotes-Moomoo

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Immunic Eyes Key Data Readout From Multiple Sclerosis Trial in 2025 | NASDAQ:IMUX
Proactive InvestorsJan 7 09:15 ET
Express News | D. Boral Capital Maintains Buy on Immunic, Maintains $17 Price Target
BenzingaJan 7 08:10 ET
Press Release: Immunic Highlights 2024 Accomplishments and Upcoming Milestones
Dow JonesJan 7 06:30 ET
Immunic CEO Dr Daniel Vitt on Successful 2024, With More to Come in the Year Ahead | NASDAQ:IMUX
Proactive InvestorsDec 13, 2024 08:00 ET
Immunic CSO Discusses Breaking the IBD Stigma to Mark Crohn's and Colitis Awareness Week | NASDAQ:IMUX
Proactive InvestorsDec 2, 2024 04:15 ET
B.Riley Financial Maintains Immunic(IMUX.US) With Buy Rating, Maintains Target Price $6
Moomoo NewsNov 26, 2024 01:32 ET · Ratings

Comments

Jaguar8

Jan 7 07:29

NEWS

$Immunic (IMUX.US)$
Immunic Highlights 2024 Accomplishments and Upcoming Milestones
Tuesday, 7th January at 6:30 am
– Top-Line Data from Phase 2 CALLIPER Trial of Vidofludimus Calcium in Progressive Multiple Sclerosis Expected in April –
– Reported Positive Outcome from Interim Analysis of Ongoing, Twin Phase 3 ENSURE Trials of Vidofludimus Calcium in Relapsing Multiple Sclerosis; Both Trials on Track to Be Completed in 2026 –
– Strengthened Management Team and Board of Directors with Key Hir...

2

SJ66Pegasus

Dec 20, 2024 07:46

$Immunic (IMUX.US)$ https://www.sec.gov/edgar/search/#/ciks=0001280776&entityName=IMMUNIC%252C%2520INC.%2520(IMUX)%2520(CIK%25200001280776)
Anything Important?

SJ66Pegasus

Dec 20, 2024 05:31

$Immunic (IMUX.US)$ 20.6% of IMUX 's stock were hold by retail investors (Institutional hold 62.16%, and Indiser hold 17.24% . Insider buying ,not much,yet still buying.Anyway Indiser can disguised in any form, we just think like them,and play predator instead.

SJ66Pegasus

Dec 20, 2024 04:40

$Immunic (IMUX.US)$ Scam Huge Scam

71261076

Dec 17, 2024 16:49

$Immunic (IMUX.US)$ The issue is they really have no product with final data while competitors move in with therapies that are FDA approved. The market for MS has many approved therapies. With each therapy approved, there is no immediate need for another one. Typically, this extends the approval time period. Even if data is very positive May of 2025 it will take 6 to 12 months for FDA to approve. So you will not see any real significant moves on this until 2026. By that time, they will need more...

1

IMUX Immunic

Trade Overview

Capital Trend

News

Comments

Trending Stocks